Divis Laboratories Ltd | DIVI - Net Income

Stock Price
6,380.50
Daily Change
125.00 2.00%
Monthly
5.36%
Yearly
13.62%
Q1 Forecast
6,171.47

Divis Laboratories Ltd reported INR5.83B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Aurobindo Pharma INR 9.1B 618.4M Dec/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
IQVIA Holdings USD 514M 183M Dec/2025
Lupin INR 11.76B 3.02B Dec/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025